Stroke. Stroke, not specified as haemorrhage or infarction
Conditions
Interventions
Intervention 1: The control group was routinely given food only / no action. Intervention 2: The intervention group consumed (lactate Zhry Capsules, 500 mg, twice a day after meal for a week).
Treatment - Drugs
The control group was routinely given food only / no action
The intervention group consumed (lactate Zhry Capsules, 500 mg, twice a day after meal for a week)
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients aged 80-30; Patients with gastrointestinal problems (constipation and abdominal distension); No obvious bleeding in the upper gastrointestinal tract; Absence of associated diseases that cause constipation, such as diabetes or hypothyroidism; Total parenteral nutrition patients who do not; Patients with GCS (5-15 have;Patients who have the same die; Hydration in patients who have identical conditions; Not receiving medications that cause constipation; Patients who do not exercise and your daily activities to help others do the work in terms of a level; Stroke patients admitted to the ICU, Taleghani Hospital, Mashhad. Exclusion criteria:The use of probiotics in the following refusal by the patient's physician to the patient; Parents patient's refusal to continue using probiotic supplements; Patients who do not tolerate gavage; Patients with systolic blood pressure lower than 100 millimeters of mercury; The patient died during the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Abdominal circumference. Timepoint: A week before the intervention and after the intervention began. Method of measurement: Using a tape measure in centimeter.;The frequency of bowel movements. Timepoint: A week before the intervention and after the intervention began. Method of measurement: Based on the registration number of daily excretion in patient chart. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side Effect. Timepoint: During the intervention and a week after the intervention. Method of measurement: Observation and scrutiny of the patient's general condition. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara Jahangiri
Sabzevar University of Medical Sciences and Health Services
Outcome results
None listed